Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate for freezing of gait in Parkinson's disease
2009-012643-42Phase 4Active
- Sponsor
- University Medical Center Groningen
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of methylphenidate in Parkinson's disease (PD) (2 arms), sponsored by University Medical Center Groningen. Primary endpoints: Behavioral task performance comparison and Mechanistic assessment of set-shifting impairments. Started Nov 2009; status: active.
02
Drugs
methylphenidate
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2009-012643-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012643-42.